Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
EmergeVest appoints Lawrence Lim as Director
-
agilon health Files Registration Statement for Proposed Initial Public Offering
-
Nomura/Instinet Downgrades Nippo Corp (1881:JP) to Neutral
-
CureApp and Jichi Medical University Collaborate on a Hypertension Therapeutics App: Primary Endpoint Met in Phase III Clinical Trial in Japan
-
Form 6-K NOMURA HOLDINGS INC For: Mar 18
-
Orchid Island Capital Announces March 2021 Monthly Dividend and February 28, 2021 RMBS Portfolio Characteristics
-
Apollo-backed Sun Country Airlines jumps 38% in Nasdaq debut
-
IPO for Sun Country Airlines (SNCY) Open 38% Higher
-
Sun Country Airlines Holdings Inc. (SNCY) Prices 9.09M Share IPO at $24/Sh
-
Sun Country Airlines Holdings, Inc. Announces Pricing of Initial Public Offering
-
Japan exports fall as China, U.S. demand weakens
-
Corporación América Airports S.A. Appoints New Chief Financial Officer
-
Municipality Finance issues GBP 250 million benchmark under MTN programme
-
Nomura/Instinet Starts Shenzhen Sunlord Electronics (002138:CH) at Buy
-
STRATA Skin Sciences Announces Independent Study Published in the Journal of The European Academy of Dermatology and Venereology
-
Fed likely to pen rosier forecasts, but no policy shift expected
-
Hayward Holdings (HAYW) IPO Opens Flat
-
Hayward Holdings Inc. (HAYW) Prices 40.28M Share IPO at $17/Sh
-
Hayward Holdings Announces Pricing of Initial Public Offering
-
BlockFi Completes $350 Million Series D
-
Sosei Heptares to receive US$2.5 million milestone payment from Formosa Pharmaceuticals
-
Fluidra Strengthens Industry Leadership Position With Acquisition of Custom Molded Products (CMP)
-
Commonwealth Care Alliance® Welcomes Three New Board Members
-
UK draws record demand for inflation-linked bond
-
Nomura/Instinet Starts Kuaishou Technology (1024:HK) at Buy
-
Applied Systems Completes Acquisition of EZLynx
-
Applied Systems Completes Acquisition of EZLynx
-
Digital Asset Custodian Komainu Closes $25M Series A to Expand Institutional Custody Offering
-
Nomura/Instinet Upgrades Dai Nippon Printing Co Ltd (7912:JP) to Buy
-
Japan picks Nomura Asset CEO to join central bank board
-
Pacific Avenue Capital Partners Announces That Allen Schaar and Chris Nealey Have Joined the Firm and Jack Marut Has Been Promoted to Vice President
-
Sun Country Airlines Holdings, Inc. Announces Launch of Initial Public Offering
-
Top 5 Things To Watch In The Stock Market This Week
-
Dialog Semiconductor Plc.: Publication of Scheme Document
-
Euro zone inflation spike seen short-lived, under ECB target for years: Reuters poll
-
DeepGreen to Combine with Sustainable Opportunities Acquisition Corporation (SOAC)
-
Top 5 Global Utility EDF Joins Hedera Governing Council
-
Hayward Holdings Launches Initial Public Offering
-
DeepGreen, Developer of the World's Largest Estimated Resource of Battery Metals for EVs, to Combine with Sustainable Opportunities Acquisition Corporation
-
Form 6-K NOMURA HOLDINGS INC For: Mar 04
-
China's CIC eyes U.S. investment after fund with Goldman raised $2.5 billion
-
APICORP sells $250 million in reopened bond deal
-
Uplight Adds New Investors Schneider Electric and Huck Capital-Led Investment Group in Deal Valued at $1.5 Billion, with Growth Capital to Accelerate the Clean Energy Ecosystem
-
Form 6-K NOMURA HOLDINGS INC For: Mar 02
-
Nomura/Instinet Starts Gland Pharma Ltd (GLAND:IN) at Neutral
-
Nomura/Instinet Starts ENNOSTAR Inc (3714:TT) at Neutral
-
Nomura/Instinet Starts Bank Jago Tbk PT (ARTO:IJ) at Buy
-
Exelixis' (EXEL) Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX in Combination with OPDIVO as First-Line Treatment for Patients with Advanced RCC
-
Exelixis’ Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) as a First-Line Treatment for Patients with Advanced Renal Cell Carcino
-
Gates Industrial Corporation plc (GTES) Prices 22M Share Secondary Offering at $15/Sh

